MiBo treatment reduces ocular surface inflammation, addressing a key factor in dry eye disease (DED).³,⁴
MiBo enhances tear film stability by improving meibum quality, which helps create a healthier tear layer.¹,²
MiBo increases the number of meibomian glands expressing liquid, improving gland function and overall tear production.⁵,⁶
With continuous, controlled heat and a gentle massage, MiBo offers immediate comfort, improving patient satisfaction.²,⁷
MiBo provides sustained improvement in symptoms, with benefits lasting up to 6 months after treatment.⁸
MiBo® delivers controlled, therapeutic heat through a patented thermoelectric handpiece combined with gentle massage, addressing meibomian gland dysfunction (MGD) at its source. Each session takes approximately 8 minutes per eye, making MiBo® easy to integrate into routine patient care without disrupting clinic flow.
With a delegable treatment protocol to staff, no disposables, and consistent patient satisfaction, MiBo® enhances clinical outcomes while driving practice efficiency and profitability. Whether as a standalone therapy or part of a comprehensive dry eye suite, MiBo® is an essential addition to any eye care practice.
MiBo® combines consistent therapeutic heat with mechanical massage to restore natural glandular function without patient discomfort, light exposure risks, or recurring costs.
Supported by peer-reviewed studies, MiBo® provides a proven, patient-preferred solution for managing chronic dry eye disease.
Delivers accurate, consistent results with low variation between users.
Quick exam process with instant, easy-to-read results and built in tutorials.
Meibography (2D/3D), NIBUT, TMH, Redness, Interferometry, Topography.
Syncs with EHR/EMR, includes treatment protocols, and supports patient follow-up via mobile app.